The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in ...

This launch builds on the successful collaboration between Dawn Health and Novartis, following the development of Ekiva MS and Ekiva PNH, and underscores the potential of digital health to transform ...

CEO Vas Narasimhan told the Wall Street Journal the company is searching for next-generation obesity drug candidates, even if ...

Super Bowl advertisers paid up to $8 million to secure a spot in television's most watched broadcast. Here's a lineup by ...

Deutsche Bank upgraded Novartis (NVS) to Buy from Hold with a price target of CHF 110, up from CHF 100. The firm says the company’s ...

Though the big game has long been hallowed ground for some of the most entertaining and memorable commercials, they often don ...

Novartis AG (NVS) stock saw a modest uptick, ending the day at $105.48 which represents a slight increase of $0.76 or 0.73% from the prior close of $104.72. The stock opened at $104.47 and touched a ...

Additionally, as the Sandoz spin-off was completed on October 2023, there were no operating results in 2024 related to discontinued operations.

Hailee Steinfeld and Issa Rae are leaving their mark on Super Bowl LIX by starring in their first Super Bowl commercials.

Fox sold out of its inventory of in-game spots by early November, with a 30-second commercial reportedly going for $7 million ...

In February 2024, the government slashed GST (Goods and Services Tax) from three major cancer drugs: Trastuzumab Deruxtecan, ...